Akihito Tsubota
Institute of Clinical Medicine and Research
Jikei University School of Medicine
163-1 Kashiwa-shita
Kashiwa
Japan
Name/email consistency: high
- Peginterferon and ribavirin treatment for hepatitis C virus infection. Tsubota, A., Fujise, K., Namiki, Y., Tada, N. World J. Gastroenterol. (2011)
- IQGAP1 and vimentin are key regulator genes in naturally occurring hepatotumorigenesis induced by oxidative stress. Tsubota, A., Matsumoto, K., Mogushi, K., Nariai, K., Namiki, Y., Hoshina, S., Hano, H., Tanaka, H., Saito, H., Tada, N. Carcinogenesis (2010)
- Bovine lactoferrin potently inhibits liver mitochondrial 8-OHdG levels and retrieves hepatic OGG1 activities in Long-Evans Cinnamon rats. Tsubota, A., Yoshikawa, T., Nariai, K., Mitsunaga, M., Yumoto, Y., Fukushima, K., Hoshina, S., Fujise, K. J. Hepatol. (2008)
- Four-week pegylated interferon alpha-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: a pilot, randomized study. Tsubota, A., Satoh, K., Aizawa, M., Takamatsu, S., Namiki, Y., Ohkusa, T., Fujise, K., Tajiri, H. World J. Gastroenterol. (2008)
- Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load. Tsubota, A., Arase, Y., Someya, T., Suzuki, Y., Suzuki, F., Saitoh, S., Ikeda, K., Akuta, N., Hosaka, T., Kobayashi, M., Kumada, H. J. Med. Virol. (2005)
- Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B. Tsubota, A., Arase, Y., Suzuki, Y., Suzuki, F., Sezaki, H., Hosaka, T., Akuta, N., Someya, T., Kobayashi, M., Saitoh, S., Ikeda, K., Kumada, H. J. Gastroenterol. Hepatol. (2005)